NeuroSigma

United States
Menasha, Wisconsin, United States, 90024

Company profile

NeuroSigma company profile

NeuroSigma, Inc. is a medical device company based in Westwood, California. NeuroSigma is focused on commercialization of its unique Trigeminal Nerve Stimulation (TNS) technology, and has a growing pipeline of treatments targeting epilepsy, depression, attention deficit hyperactivity disorder (ADHD), and post-traumatic stress disorder (PTSD). NeuroSigma is actively engaged in cutting-edge preclinical research and development, as well as groundbreaking Phase I, II, & III clinical trials.

Business identity

Contact email
[email protected]
Phone number
3104793114
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2008-01-01, Year

Headquarters

Postal code
90024
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
5
Total equity funding
$6.5M
Last funding
Series Unknown / $1M / 2025-12-15
Last equity funding
Series Unknown / $1M
Investors
2
Lead investors
2
Founders
2
Articles
42

Founders and investors

Founders

Alejandro CovalinLodwrick Cook

Lead investors

Checkmate CapitalKT Corp

Investors

Checkmate CapitalKT Corp